J&J Increases Alza Ante By $5 Bil. Over Abbott: Concerta Has J&J Upbeat

Johnson & Johnson is offering about 67% ($5 bil.) more than Abbott did in 1999 to bring Alza's $700 mil. annual sales product line and its extended-release product development skills into the J&J family.